de Koning, W.; van Eijck, C.W.F.; van der Sijde, F.; Strijk, G.J.; Oostvogels, A.A.M.; Debets, R.; van Eijck, C.H.J.; Mustafa, D.A.M.
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients. Cancers 2023, 15, 4349.
https://doi.org/10.3390/cancers15174349
AMA Style
de Koning W, van Eijck CWF, van der Sijde F, Strijk GJ, Oostvogels AAM, Debets R, van Eijck CHJ, Mustafa DAM.
Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients. Cancers. 2023; 15(17):4349.
https://doi.org/10.3390/cancers15174349
Chicago/Turabian Style
de Koning, Willem, Casper W. F. van Eijck, Fleur van der Sijde, Gaby J. Strijk, Astrid A. M. Oostvogels, Reno Debets, Casper H. J. van Eijck, and Dana A. M. Mustafa.
2023. "Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients" Cancers 15, no. 17: 4349.
https://doi.org/10.3390/cancers15174349
APA Style
de Koning, W., van Eijck, C. W. F., van der Sijde, F., Strijk, G. J., Oostvogels, A. A. M., Debets, R., van Eijck, C. H. J., & Mustafa, D. A. M.
(2023). Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients. Cancers, 15(17), 4349.
https://doi.org/10.3390/cancers15174349